Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | Zendy

Ken Okumura | Zendy; Masaharu Akao | Zendy; Tetsuro Yoshida | Zendy; Masahito Kawata | Zendy; Osamu Okazaki | Zendy; Shintaro Akashi | Zendy; Kenichi Eshima | Zendy; Kimihiko Tanizawa | Zendy; M. Fukuzawa | Zendy; Takuya Hayashi | Zendy; Masahiro Akishita | Zendy; Gregory Y.H. Lip | Zendy; Takeshi Yamashita | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

Author(s) -

Ken Okumura,

Masaharu Akao,

Tetsuro Yoshida,

Masahito Kawata,

Osamu Okazaki,

Shintaro Akashi,

Kenichi Eshima,

Kimihiko Tanizawa,

M. Fukuzawa,

Takuya Hayashi,

Masahiro Akishita,

Gregory Y.H. Lip,

Takeshi Yamashita

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2012883

Subject(s) - atrial fibrillation , edoxaban , medicine , stroke (engine) , cardiology , anticoagulant , intensive care medicine , oral anticoagulant , warfarin , dabigatran , mechanical engineering , engineering

Implementation of appropriate oral anticoagulant treatment for the prevention of stroke in very elderly patients with atrial fibrillation is challenging because of concerns regarding bleeding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research